Finanzen von SANUWAVE Health Inc (SNWV)SNWVSANUWAVE Health Inc

SANUWAVE Health Inc (SNWV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Accessories and parts, accounting for 65.8% of total sales, equivalent to $6.69M. Other significant revenue streams include Product and Other Revenue. Understanding this composition is critical for investors evaluating how SNWV navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, SANUWAVE Health Inc maintains a gross margin of 73.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.88%, while the net margin is -7.00%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively SNWV converts its operational activities into shareholder value.

In the context of the broader market, SNWV competes directly with industry leaders such as SRTS and DAVI. With a market capitalization of $19.00M, it holds a significant position in the sector. When comparing efficiency, SNWV's gross margin of 73.65% stands against SRTS's 33.58% and DAVI's N/A. Such benchmarking helps identify whether SANUWAVE Health Inc is trading at a premium or discount relative to its financial performance.

Sanuwave's revenue has been declining, with Q2 2026 revenue of $9.6 million, down from $10.1 million in Q2 2025. The gross margin remains relatively high at around 73.65%, but net income has been negative, indicating ongoing losses.